The demand for IVF is surging globally. getty

Conceivable Life Sciences has announced a $50 million Series A round to amplify its work and efforts to bring AI driven automation and advanced robotic precision to the In Vitro Fertilization (IVF) space. The round will be led by numerous prominent investors including ARTIS ventures, Stride and ACME ventures.

Currently, the IVF lifecycle is an incredibly cumbersome and manually driven workflow which depends heavily on human experience, dexterity and vision. This often leads to a certain degree of inconsistency in outcomes and variability in the experience for families undertaking this already onerous process. In fact, the propensity for error is extremely stressful; the average cost per IVF cycle in the United States can range anywhere be

See Full Page